Apixaban Versus Enoxaparin for Postpartum Venous Thromboembolism Prophylaxis

Starting soon · Not applicable

Conditions studied: Postpartum, DVT Prophylaxis

In brief

The purpose of this study is to compare the use of oral apixaban to subcutaneous enoxaparin for venous thromboembolism (VTE) prophylaxis in postpartum women at high risk for VTE. The primary goal is to evaluate medication adherence rates and patient satisfaction with the treatment.

Key facts

Study ID
NCT07716332
Run by
Ron Beloosesky MD
People needed
150
Starts
2026-07-01
Expected to finish
2027-04-01
Last updated by the study team
2026-07-21

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.